INTERNATIONAL PATENT: ATAI THERAPEUTICS, INC. FILES APPLICATION FOR "CONTROLLED TRANSMUCOSAL RELEASE OF DMT IN COMBINATION WITH A MONOAMINE OXIDASE INHIBITOR"

GENEVA, Aug. 19 -- ATAI THERAPEUTICS, INC. (c/o Industrious NYC250 West 34 St.New York, New York 10119) filed a patent application (PCT/US2025/014571) for "CONTROLLED TRANSMUCOSAL RELEASE OF DMT IN COMBINATION WITH A MONOAMINE OXIDASE INHIBITOR" on Feb 05, 2025. With publication no. WO/2025/170990, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHORT, Glenn (c/o Atai Therapeutics, Inc.Industrious NYC.250 West 34th St.New York, New York 10119), RAO, Srinivas G. (c/o Atai Therapeutics, Inc.Industrious NYC.250 West 34th St....